Literature DB >> 219033

Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

L K Curtiss, T S Edgington.   

Abstract

Reports by a number of investigators have described the thymus-derived (T)-cell dependence of immunoglobulin synthesis by pokeweed mitogen (PWM) stimulated human peripheral blood bone marrow-derived (B) cells. Because of the cooperative nature of this in vitro system, it was chosen for examination of the differential effects of low density lipoprotein inhibitor (LDL-In) on B- and T-cell functions. Supernates from 7-d cultures that contained either peripheral blood mononuclear cells (PBM) or combinations of isolated lymphocyte populations were assayed for immunoglobulin (Ig)G by competitive inhibition radio-immunoassay. LDL-In suppression of whole PBM IgG synthesis occurred at 5-20 mug protein/ml and was independent of PWM concentration. Maximal suppression required preincubation of cells with LDL-In before stimulation. Suppression was also observed when B cells alone were exposed for 24 h to LDL-In before PWM stimulation; these suppressed B cells were not rescued by normal T cells. Exposure of T cells alone to low doses of LDL-In for 24 h augmented, but high doses suppressed, IgG synthesis, suggesting a differential effect on T-helper vs T-suppressor cell populations. Independent LDL-In exposure of T-helper or T-suppressor cell enriched populations, separated by rosetting with IgG- or IgM-coated ox erythrocytes, identified the T-suppressor cell populations as the most sensitive of the lymphocyte populations tested. The sensitivities of lymphocyte subpopulations to LDL-In, relative to PBM, were 2.8, 1.2, and 0.3 for the T-suppressor cells, B cells and T-helper cells, respectively. Thus, both B and T lymphocytes are sensitive to and can be regulated by LDL-In. In addition, the biologic activity observed when unseparated PBM are exposed to LDL-In appears to represent a composite of the sensitivity of each of the lymphocyte subpopulations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219033      PMCID: PMC371939          DOI: 10.1172/JCI109289

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

2.  Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation.

Authors:  L K Curtiss; T S Edgington
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

3.  Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

4.  T-cell regulation of immunoglobulin synthesis and proliferation in pokeweed (Pa-1)-stimulated human lymphocyte cultures.

Authors:  G Janossy; E Gomez de la Concha; A Luquetti; M J Snajdr; M J Waxdal; T A Platts-Mills
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

5.  In vitro immune response of human peripheral lymphocytes. I. The mechanism(s) involved in T cell helper functions in the pokeweed mitogen-induced differentiation and proliferation of B cells.

Authors:  T Hirano; T Kuritani; T Kishimoto; Y Yamamura
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

6.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation.

Authors:  P E Lipsky; W W Ginsburg; F D Finkelman; M Ziff
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

8.  Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

9.  In vivo suppression of the primary immune response by a species of low density serum lipoprotein.

Authors:  L K Curtiss; D H DeHeer; T S Edgington
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  6 in total

1.  Surface properties of LDL-binding lymphocytes in human peripheral blood.

Authors:  K Hiramatsu; H Sakai; M Endoh; S Arimori
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

2.  Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.

Authors:  R Terkeltaub; L K Curtiss; A J Tenner; M H Ginsberg
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

3.  Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide.

Authors:  G A Levy; B S Schwartz; L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase.

Authors:  K D O'Brien; S S Deeb; M Ferguson; T O McDonald; M D Allen; C E Alpers; A Chait
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

5.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

Authors:  J K Boyles; R E Pitas; E Wilson; R W Mahley; J M Taylor
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages.

Authors:  Z Werb; J R Chin
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.